Clinical trial
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
NCT02100904 · University of California, San Francisco, Other · Active, not recruiting
Key facts
| NCT number | NCT02100904 |
|---|---|
| Title | Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry |
| Official title | Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry |
| Acronym | ULTRA Registry |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Uterine Fibroids |
| Intervention type | Procedure |
| Interventions | Radiofrequency ablation of fibroids, Myomectomy of fibroids |
| Enrollment | 578 |
| Start date | May 1, 2014 |
| Primary completion | Jan 1, 2026 |
| Completion | Jan 1, 2026 |
| First posted | Apr 1, 2014 |
| Last update posted | Dec 26, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: